Literature DB >> 34016623

Quantitative Analysis of Tyrosine Phosphorylation from FFPE Tissues Reveals Patient-Specific Signaling Networks.

Ishwar N Kohale1,2,3, Danielle M Burgenske4, Ann C Mladek4, Katrina K Bakken4, Jenevieve Kuang2,3, Judy C Boughey5, Liewei Wang6, Jodi M Carter7, Eric B Haura8, Matthew P Goetz9, Jann N Sarkaria4, Forest M White10,2,3.   

Abstract

Human tissue samples commonly preserved as formalin-fixed paraffin-embedded (FFPE) tissues after diagnostic or surgical procedures in the clinic represent an invaluable source of clinical specimens for in-depth characterization of signaling networks to assess therapeutic options. Tyrosine phosphorylation (pTyr) plays a fundamental role in cellular processes and is commonly dysregulated in cancer but has not been studied to date in FFPE samples. In addition, pTyr analysis that may otherwise inform therapeutic interventions for patients has been limited by the requirement for large amounts of frozen tissue. Here we describe a method for highly sensitive, quantitative analysis of pTyr signaling networks, with hundreds of sites quantified from one to two 10-μm sections of FFPE tissue specimens. A combination of optimized magnetic bead-based sample processing, optimized pTyr enrichment strategies, and tandem mass tag multiplexing enabled in-depth coverage of pTyr signaling networks from small amounts of input material. Phosphotyrosine profiles of flash-frozen and FFPE tissues derived from the same tumors suggested that FFPE tissues preserve pTyr signaling characteristics in patient-derived xenografts and archived clinical specimens. pTyr analysis of FFPE tissue sections from breast cancer tumors as well as lung cancer tumors highlighted patient-specific oncogenic driving kinases, indicating potential targeted therapies for each patient. These data suggest the capability for direct translational insight from pTyr analysis of small amounts of FFPE tumor tissue specimens. SIGNIFICANCE: This study reports a highly sensitive method utilizing FFPE tissues to identify dysregulated signaling networks in patient tumors, opening the door for direct translational insights from FFPE tumor tissue banks in hospitals. ©2021 The Authors; Published by the American Association for Cancer Research.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 34016623      PMCID: PMC8286342          DOI: 10.1158/0008-5472.CAN-21-0214

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  43 in total

1.  Cytoscape: a software environment for integrated models of biomolecular interaction networks.

Authors:  Paul Shannon; Andrew Markiel; Owen Ozier; Nitin S Baliga; Jonathan T Wang; Daniel Ramage; Nada Amin; Benno Schwikowski; Trey Ideker
Journal:  Genome Res       Date:  2003-11       Impact factor: 9.043

2.  Universal and confident phosphorylation site localization using phosphoRS.

Authors:  Thomas Taus; Thomas Köcher; Peter Pichler; Carmen Paschke; Andreas Schmidt; Christoph Henrich; Karl Mechtler
Journal:  J Proteome Res       Date:  2011-11-10       Impact factor: 4.466

3.  Quantitative proteomic analysis of phosphotyrosine-mediated cellular signaling networks.

Authors:  Yi Zhang; Alejandro Wolf-Yadlin; Forest M White
Journal:  Methods Mol Biol       Date:  2007

4.  Manual validation of peptide sequence and sites of tyrosine phosphorylation from MS/MS spectra.

Authors:  Amy M Nichols; Forest M White
Journal:  Methods Mol Biol       Date:  2009

5.  Phosphotyrosine-based-phosphoproteomics scaled-down to biopsy level for analysis of individual tumor biology and treatment selection.

Authors:  Mariette Labots; Johannes C van der Mijn; Robin Beekhof; Sander R Piersma; Richard R de Goeij-de Haas; Thang V Pham; Jaco C Knol; Henk Dekker; Nicole C T van Grieken; Henk M W Verheul; Connie R Jiménez
Journal:  J Proteomics       Date:  2017-04-23       Impact factor: 4.044

6.  Ultra-deep tyrosine phosphoproteomics enabled by a phosphotyrosine superbinder.

Authors:  Yangyang Bian; Lei Li; Mingming Dong; Xuguang Liu; Tomonori Kaneko; Kai Cheng; Huadong Liu; Courtney Voss; Xuan Cao; Yan Wang; David Litchfield; Mingliang Ye; Shawn S-C Li; Hanfa Zou
Journal:  Nat Chem Biol       Date:  2016-09-19       Impact factor: 15.040

7.  Ischemia in tumors induces early and sustained phosphorylation changes in stress kinase pathways but does not affect global protein levels.

Authors:  Philipp Mertins; Feng Yang; Tao Liu; D R Mani; Vladislav A Petyuk; Michael A Gillette; Karl R Clauser; Jana W Qiao; Marina A Gritsenko; Ronald J Moore; Douglas A Levine; Reid Townsend; Petra Erdmann-Gilmore; Jacqueline E Snider; Sherri R Davies; Kelly V Ruggles; David Fenyo; R Thomas Kitchens; Shunqiang Li; Narciso Olvera; Fanny Dao; Henry Rodriguez; Daniel W Chan; Daniel Liebler; Forest White; Karin D Rodland; Gordon B Mills; Richard D Smith; Amanda G Paulovich; Matthew Ellis; Steven A Carr
Journal:  Mol Cell Proteomics       Date:  2014-04-09       Impact factor: 5.911

8.  Quantitative analysis of signaling networks across differentially embedded tumors highlights interpatient heterogeneity in human glioblastoma.

Authors:  Hannah Johnson; Forest M White
Journal:  J Proteome Res       Date:  2014-06-24       Impact factor: 4.466

9.  PANTHER version 14: more genomes, a new PANTHER GO-slim and improvements in enrichment analysis tools.

Authors:  Huaiyu Mi; Anushya Muruganujan; Dustin Ebert; Xiaosong Huang; Paul D Thomas
Journal:  Nucleic Acids Res       Date:  2019-01-08       Impact factor: 16.971

10.  Phosphotyrosine profiling of human cerebrospinal fluid.

Authors:  Gajanan Sathe; Chan Hyun Na; Santosh Renuse; Anil Madugundu; Marilyn Albert; Abhay Moghekar; Akhilesh Pandey
Journal:  Clin Proteomics       Date:  2018-09-12       Impact factor: 3.988

View more
  5 in total

Review 1.  Phosphoproteomics: a valuable tool for uncovering molecular signaling in cancer cells.

Authors:  Jacqueline S Gerritsen; Forest M White
Journal:  Expert Rev Proteomics       Date:  2021-09-16       Impact factor: 4.250

2.  Dendritic cell-mediated cross presentation of tumor-derived peptides is biased against plasma membrane proteins.

Authors:  Tim B Fessenden; Lauren E Stopfer; Fiona Chatterjee; Julian Zulueta; Josh Mesfin; Therese Cordero Dumit; Irene Reijers; Esmee P Hoefsmit; Christian Blank; Forest White; Stefani Spranger
Journal:  J Immunother Cancer       Date:  2022-07       Impact factor: 12.469

3.  Multimodal platform for assessing drug distribution and response in clinical trials.

Authors:  Begoña G C Lopez; Ishwar N Kohale; Ziming Du; Ilya Korsunsky; Walid M Abdelmoula; Yang Dai; Sylwia A Stopka; Giorgio Gaglia; Elizabeth C Randall; Michael S Regan; Sankha S Basu; Amanda R Clark; Bianca-Maria Marin; Ann C Mladek; Danielle M Burgenske; Jeffrey N Agar; Jeffrey G Supko; Stuart A Grossman; Louis B Nabors; Soumya Raychaudhuri; Keith L Ligon; Patrick Y Wen; Brian Alexander; Eudocia Q Lee; Sandro Santagata; Jann Sarkaria; Forest M White; Nathalie Y R Agar
Journal:  Neuro Oncol       Date:  2022-01-05       Impact factor: 13.029

4.  Comparative Assessment of Quantification Methods for Tumor Tissue Phosphoproteomics.

Authors:  Yang Zhang; Benjamin Dreyer; Natalia Govorukhina; Alexander M Heberle; Saša Končarević; Christoph Krisp; Christiane A Opitz; Pauline Pfänder; Rainer Bischoff; Hartmut Schlüter; Marcel Kwiatkowski; Kathrin Thedieck; Peter L Horvatovich
Journal:  Anal Chem       Date:  2022-07-26       Impact factor: 8.008

5.  Identification of Src Family Kinases as Potential Therapeutic Targets for Chemotherapy-Resistant Triple Negative Breast Cancer.

Authors:  Ishwar N Kohale; Jia Yu; Yongxian Zhuang; Xiaoyang Fan; Raven J Reddy; Jason Sinnwell; Krishna R Kalari; Judy C Boughey; Jodi M Carter; Matthew P Goetz; Liewei Wang; Forest M White
Journal:  Cancers (Basel)       Date:  2022-08-30       Impact factor: 6.575

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.